CanSinoBIOs

CanSinoBIO’s inhaled COVID booster stronger against BA.1 Omicron subvariant than Sinovac shot

BEIJING (Reuters) – Chinese language vaccine agency CanSino Biologic’s inhalation-based candidate elicited a greater antibody response as a booster towards…